Dietary vitamin A shows promise in Alzheimer’s disease intervention, study finds

FHS
March 28, 2024
11:51 pm

Study explored the impact of dietary vitamin A on gut microbiota and intestinal transcriptome, revealing its potential in Alzheimer’s disease (AD) pathology and cognitive functions in mice.

Peter Orszag wants the FTC and DOJ to stop challenging health care mergers

Peter Orszag was instrumental in crafting the Affordable Care Act. Now, he wants federal antitrust authorities to ease up on their sharp scrutiny of health

August 19, 2024

Canopy Growth Burns Cash Again in Q3

Canopy Growth Reports Third Quarter Fiscal Year 2024 Financial Results; Achieves Third Quarter of Sequential Revenue Growth across Canada Cannabis Businesses and a Record Quarter

February 9, 2024

AbbVie’s migraine medication Qulipta gets positive CHMP opinion – Pharmaceutical Technology

AbbVie’s Qulipta could bring relief to over 40 million migraine sufferers in Europe. Source: Shutterstock / Tunatura. AbbVie announced the European Medicines Agency’s (EMA) Committee

June 23, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.